| 查看: 565 | 回复: 1 | |||
jinqingxian至尊木虫 (著名写手)
有机脑力学-合成手艺学
|
[交流]
安帕来斯
|
| 谁知道安帕来斯的情况，是否允许上市？国内还是国外？销售和疗效情况如何？ |
回复此楼» 猜你喜欢
数据驱动智能故障诊断技术应用与实践
已经有0人回复
-
基于AI智能算法的装备结构可靠性分析与优化设计技术
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有170人回复
-
求助求助
已经有0人回复
-
农业资源与环境、智慧农业专业本科生毕业论文课题选题求助
已经有1人回复
-
人工智能赋能聚合物及复合材料模型应用与实践
已经有0人回复
-
各国和国际组织现行药典注射用水质量标准
已经有0人回复
-
求助用微谱数据库查询
已经有0人回复
-
计算化学与人工智能驱动的MOFs性能预测与筛选技术
已经有0人回复
-
研三实验求指导
已经有0人回复
-
金属材料多尺度计算模拟技术与应用：微观机理到宏观性能的集成工作
已经有0人回复
thecoldest
金虫 (正式写手)
- 应助: 148 (高中生)
- 金币: 1772.7
- 散金: 30
- 红花: 33
- 帖子: 588
- 在线: 116.3小时
- 虫号: 1119567
- 注册: 2010-10-11
- 专业: 药物分析
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
|
应该是因临床试验效果不好，被原研制方Cortex放弃了 http://www.trademarkia.com/ampakine-77965906.html ABANDONED - NO STATEMENT OF USE FILED 11/5/2012 https://en.wikipedia.org/wiki/CX-516 CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to. |
2楼2016-01-03 09:48:42